Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA STADAGEN 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA STADAGEN 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Laboratorio Stada S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2b959c0d214ebf7d
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA STADAGEN 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 85134
Holder Company Name: Laboratorio Stada S.L.
Marketing Company Name: Laboratorio Stada S.L.
Authorization Date: 2020-06-08
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg/5 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorio Stada S.L.

OLMESARTAN MEDOXOMILO

20 mg

AMLODIPINO BESILATO

6,95 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 8, 2020

Approval ID

2b959c0d214ebf7d

Type

Standard